Ranbaxy Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on March 28, 2008, inter-alia, for consideration of Audited Accounts for the year ended December 31, 2007 and recommendation of final dividend on Equity Shares for the year ended December 31, 2007.
This entry was posted
on Tuesday, March 18th, 2008 at 10:41 am and is filed under Company News.
You can follow any responses to this entry through the RSS 2.0 feed.
You can leave a response, or trackback from your own site.
